Hepatitis B reactivation in a patient with rheumatoid arthritis with antibodies to hepatitis B surface antigen treated with rituximab.
about
Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendationsHepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review-ScreenedRisk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs.Safety of Repeated Open-Label Treatment Courses of Intravenous Ofatumumab, a Human Anti-CD20 Monoclonal Antibody, in Rheumatoid Arthritis: Results from Three Clinical Trials.Rituximab for the treatment of rheumatoid arthritis: an update.Biological therapy in arthritis patients with hepatitis B or C infection: a multicenter retrospective case series.
P2860
Hepatitis B reactivation in a patient with rheumatoid arthritis with antibodies to hepatitis B surface antigen treated with rituximab.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatitis B reactivation in a ...... ntigen treated with rituximab.
@en
Hepatitis B reactivation in a ...... ntigen treated with rituximab.
@nl
type
label
Hepatitis B reactivation in a ...... ntigen treated with rituximab.
@en
Hepatitis B reactivation in a ...... ntigen treated with rituximab.
@nl
prefLabel
Hepatitis B reactivation in a ...... ntigen treated with rituximab.
@en
Hepatitis B reactivation in a ...... ntigen treated with rituximab.
@nl
P2093
P2860
P1433
P1476
Hepatitis B reactivation in a ...... ntigen treated with rituximab.
@en
P2093
M Raptopoulou-Gigi
T Georgiou
P2860
P577
2013-01-01T00:00:00Z